Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL

Atherosclerosis

Volumn 173, Issue 2, 2004, Pages 197-202

  Kinoshita, Makoto ^a   Fujita, Mineko ^a   Usui, Shinichi ^b   Maeda, Yoko ^a   Kudo, Mikiko ^a   Hirota, Daisuke ^a   Suda, Takaoki ^a   Taki, Masanari ^a   Okazaki, Mitsuyo ^c   Teramoto, Tamio ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Tokyo Medical and Dental University ^*  (Japan)

Author keywords

Apo; Apolipoprotein; Atherosclerosis; CE; CETP; CETP deficiency; Cholesterol ester; Cholesteryl ester transfer protein; LCAT; Lecithin:cholesterol acyltransferase; Lipoprotein deficient serum; LPDS; Scavenger receptor class B type I; SR BI

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHO CELL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; GENETIC TRANSFECTION; HUMAN; LIPID ANALYSIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIGENS, CD36; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CELLS, CULTURED; CHO CELLS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CRICETINAE; CRICETULUS; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; PROBABILITY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; REFERENCE VALUES; SAMPLING STUDIES; SCAVENGER RECEPTORS, CLASS B; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 11144357090     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.014     Document Type: Article

References (30)

1. Eisenberg S. High density lipoprotein metabolism. J. Lipid Res. 25:1984;1017-1058.
2. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
3. Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86:1990;379-384.
4. Acton S., Rigotti A., Landschulz K.T.et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
5. Krieger M. The best of cholesterols, the worst of cholesterols: a tale of two receptors. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4077-4080.
6. Ng D.S., Francone O.L., Forte T.M.et al. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J. Biol. Chem. 272:1997;15777-15781.
7. Rigotti A., Edelman E.R., Seifert P.et al. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J. Biol. Chem. 271:1996;33545-33549.
8. Ji Y., Jian B., Wang N.et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:1997;20982-20985.
9. Arai T., Wang N., Bezouevski M.et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274:1999;2366-2371.
10. Wang N., Arai T., Ji Y.et al. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273:1998;32920-32926.
11. Yamashita S., Hui D.Y., Sprecher D.L.et al. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem. Biophys. Res. Comm. 170:1990;1346-1351.
12. Inazu A., Brown M.L., Hesler C.B.et al. Increased high density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323:1990;1234-1238.
13. Koizumi J., Inazu A., Yagi K.et al. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 90:1991;189-196.
14. Marotti K.R., Castle C.K., Boyle T.P.et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364:1993;73-75.
15. Hayek T., Masucci-Magoulas L., Jiang X.et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96:1995;2071-2074.
16. Oliveira H.C., Ma L., Milne R.et al. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler Thromb. Vasc. Biol. 17:1997;1045-1052.
17. Ishigami M., Yamashita S., Sakai N.et al. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency cannot protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. 116:1994;257-262.
18. Zhong S., Sharp D.S., Grove J.S.et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97:1996;2917-2923.
19. Hirano K., Yamashita S., Nakajima N.et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler. Thromb. Vasc. Biol. 17:1997;1053-1059.
20. Fukasawa M., Adachi H., Hirota K.et al. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apototic cells. Exp. Cell Res. 222:1996;246-250.
21. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1354.
22. Roberts D.C.K., Miller N.E., Price S.G.L.et al. An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro. Biochem. J. 226:1985;319-322.
23. Usui S., Nakamura M., Jitsukata K.et al. Assessment of between-instrument variations in a HPLC method for serum lipoproteins, and its traceability to reference methods for total cholesterol and HDL-cholesterol. Clin. Chem. 46:2000;63-72.
24. Kinoshita M., Kawamura M., Maeda T.et al. Apolipoprotein E accelerates the efflux of cholesterol from macrophages: mechanism of xanthoma formation in apolipoprotein E deficiency. J. Athero. Thromb. 6:2000;22-27.
25. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
26. Lowry O.H., Rosebrough N.J., Farr A.L.et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Yamashita S., Hui D.Y., Wetterau J.R.et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism. 40:1991;756-763.
28. Yamashita S., Sprecher D.L., Sakai N.et al. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J. Clin. Invest. 86:1990;688-695.
29. Ueda Y., Royer L., Gong E.et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274:1999;7165-7171.
30. Rigotti A., Trigatti B.L., Penman M.et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12610-12615.